Skip to main content
. 2019 Feb 28;43(5):590–606. doi: 10.4093/dmj.2018.0134

Fig. 2. Percentage of patients who achieved glycosylated hemoglobin (HbA1c) <7.0% in overall patients and those with baseline HbA1c <8.0%. aP<0.05 between add-on therapy and switch therapy.

Fig. 2